INCY241220P32500
- 0.12
- 0.000.00%
Incyte Newsroom
S&P and Nasdaq on Track for Third Record Close This Week | Live Stock
Incyte Gains Amid Takeover Speculation
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Incyte Insider Sold Shares Worth $455,544, According to a Recent SEC Filing
Insider Sale: EVP of $INCY (INCY) Sells 5,683 Shares
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
Incyte To Present At Citi's 2024 Global Healthcare Conference; Webcast At 8:00 AM ET
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
December Starts With a Mixed Market | Live Stock
Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report?
RBC Capital Sticks to Its Hold Rating for Incyte (INCY)
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Incyte Announces Updated Presentation Time for Upcoming Investor Conference
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Express News | Incyte To Present Late-Breaking Tafasitamab Data In Follicular Lymphoma At ASH 2024 Alongside 20 Oncology Portfolio Updates, Including Phase 3 InMIND Results And Virtual Analyst Event On December 12
S&P 500, Dow Hit Records Right After Open | Live Stock
TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Raises Target Price to $86
TD Cowen Remains a Buy on Incyte (INCY)